VÍCTOR
ROCA ARBONES
Investigador hasta 2008
Bonaventura
Clotet Sala
Publicaciones en las que colabora con Bonaventura Clotet Sala (6)
2015
-
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study
PLoS ONE, Vol. 10, Núm. 10
-
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
PLoS Medicine, Vol. 12, Núm. 3
2009
-
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/ emtricitabine in HIV-1-infected patients with virological suppression
Journal of Acquired Immune Deficiency Syndromes, Vol. 51, Núm. 3, pp. 290-297
-
Efficacy and safety of switching from boosted lopinavir to boosted atazanavir in patients with virological suppression receiving a lpv/r-containing haart: The atazip study
Journal of Acquired Immune Deficiency Syndromes, Vol. 51, Núm. 1, pp. 29-36
-
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor - sparing strategy: Results from the multicenter study with nevirapine and kaletra (MULTTNEKA)
Clinical Infectious Diseases, Vol. 49, Núm. 6, pp. 892-900
2008
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313